Literature DB >> 19389921

Site specificity of agonist and second messenger-activated kinases for somatostatin receptor subtype 2A (Sst2A) phosphorylation.

Qisheng Liu1, Mark S Bee, Agnes Schonbrunn.   

Abstract

Somatostatin receptor subtype 2A (sst2A) mediates many of the endocrine and neuronal actions of somatostatin and is the target of somatostatin analogs in cancer therapy. As with many G-protein-coupled receptors, agonist stimulation causes sst2A receptor desensitization and internalization, events that require receptor phosphorylation. Furthermore, heterologous receptor activation of protein kinase C (PKC) also increases sst2A receptor phosphorylation and internalization. Here we analyzed a series of sst2A receptor mutants biochemically to identify residues in the receptor carboxyl terminus that were phosphorylated upon agonist stimulation, and we then generated four phosphorylation-sensitive antibodies to those residues. Once the selectivity of each antibody for its phosphorylated and nonphosphorylated target sequence was determined, the phospho-site-specific antibodies were used to demonstrate that somatostatin treatment of Chinese hamster ovary (CHO) cells expressing the wild type sst2A receptor increased phosphorylation on five residues in the receptor C terminus: Ser341, Ser343, Ser348, Thr353, and Thr354. Phorbol 12-myristate 13-acetate (PMA) increased receptor phosphorylation only on Ser343. Inhibition of PKC blocked PMA but not somatostatin stimulation, showing that different kinases catalyzed Ser343 phosphorylation. In contrast, somatostatin-stimulated sst2A receptor phosphorylation was inhibited by knockdown of G-protein coupled receptor kinase-2 with siRNA. Somatostatin increased sst2A receptor phosphorylation on the same five residues in GH4C1 pituitary cells as in CHO cells. However, PMA stimulated sst2A receptor phosphorylation on both Ser343 and Ser348 in GH4C1 cells. These results characterize the complex pattern of sst2A receptor phosphorylation by agonist and second messenger-activated kinases for the first time and indicate that cell type-specific regulation of sst2A receptor phosphorylation occurs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389921      PMCID: PMC2701454          DOI: 10.1124/mol.108.054262

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  34 in total

Review 1.  Characterisation of somatostatin sst2 receptor splice variants.

Authors:  S L Cole; M Schindler
Journal:  J Physiol Paris       Date:  2000 May-Aug

Review 2.  Regulation of receptor trafficking by GRKs and arrestins.

Authors:  Catherine A C Moore; Shawn K Milano; Jeffrey L Benovic
Journal:  Annu Rev Physiol       Date:  2007       Impact factor: 19.318

Review 3.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

Review 4.  G-protein-coupled receptor phosphorylation: where, when and by whom.

Authors:  A B Tobin
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

5.  Protein kinase C activation stimulates the phosphorylation and internalization of the sst2A somatostatin receptor.

Authors:  R W Hipkin; Y Wang; A Schonbrunn
Journal:  J Biol Chem       Date:  2000-02-25       Impact factor: 5.157

6.  Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding.

Authors:  Q Liu; D A Dewi; W Liu; M S Bee; A Schonbrunn
Journal:  Mol Pharmacol       Date:  2007-11-02       Impact factor: 4.436

Review 7.  Somatostatin/somatostatin receptor signalling: phosphotyrosine phosphatases.

Authors:  Tullio Florio
Journal:  Mol Cell Endocrinol       Date:  2007-08-31       Impact factor: 4.102

8.  Selective regulation of somatostatin receptor subtype signaling: evidence for constitutive receptor activation.

Authors:  Anat Ben-Shlomo; Oxana Pichurin; Nicole J Barshop; Kolja A Wawrowsky; John Taylor; Michael D Culler; Vera Chesnokova; Ning-Ai Liu; Shlomo Melmed
Journal:  Mol Endocrinol       Date:  2007-07-03

9.  A functional comparison of recombinant and native somatostatin sst2 receptor variants in epithelia.

Authors:  N D Holliday; I R Tough; H M Cox
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

10.  KinasePhos 2.0: a web server for identifying protein kinase-specific phosphorylation sites based on sequences and coupling patterns.

Authors:  Yung-Hao Wong; Tzong-Yi Lee; Han-Kuen Liang; Chia-Mao Huang; Ting-Yuan Wang; Yi-Huan Yang; Chia-Huei Chu; Hsien-Da Huang; Ming-Tat Ko; Jenn-Kang Hwang
Journal:  Nucleic Acids Res       Date:  2007-05-21       Impact factor: 16.971

View more
  18 in total

Review 1.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

2.  Phosphorylation of sst2 receptors in neuroendocrine tumors after octreotide treatment of patients.

Authors:  Beatrice Waser; Renzo Cescato; Qisheng Liu; Yachu J Kao; Meike Körner; Emanuel Christ; Agnes Schonbrunn; Jean Claude Reubi
Journal:  Am J Pathol       Date:  2012-05       Impact factor: 4.307

3.  Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists.

Authors:  Yachu J Kao; Madhumita Ghosh; Agnes Schonbrunn
Journal:  Mol Endocrinol       Date:  2011-04-14

Review 4.  Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5.

Authors:  Stefan Schulz; Andreas Lehmann; Andrea Kliewer; Falko Nagel
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

5.  Structural determinants of agonist-selective signaling at the sst(2A) somatostatin receptor.

Authors:  Falko Nagel; Christian Doll; Florian Pöll; Andrea Kliewer; Helmut Schröder; Stefan Schulz
Journal:  Mol Endocrinol       Date:  2011-02-17

6.  Differential temporal and spatial regulation of somatostatin receptor phosphorylation and dephosphorylation.

Authors:  Madhumita Ghosh; Agnes Schonbrunn
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

Review 7.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.

Authors:  Thomas Günther; Giovanni Tulipano; Pascal Dournaud; Corinne Bousquet; Zsolt Csaba; Hans-Jürgen Kreienkamp; Amelie Lupp; Márta Korbonits; Justo P Castaño; Hans-Jürgen Wester; Michael Culler; Shlomo Melmed; Stefan Schulz
Journal:  Pharmacol Rev       Date:  2018-10       Impact factor: 25.468

8.  Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line.

Authors:  Valeria Cambiaghi; Eleonora Vitali; Diego Morone; Erika Peverelli; Anna Spada; Giovanna Mantovani; Andrea Gerardo Lania
Journal:  Endocrine       Date:  2016-07-12       Impact factor: 3.633

Review 9.  Pituitary somatostatin receptor signaling.

Authors:  Anat Ben-Shlomo; Shlomo Melmed
Journal:  Trends Endocrinol Metab       Date:  2010-02-09       Impact factor: 12.015

10.  Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.

Authors:  Florian Pöll; Diana Lehmann; Susann Illing; Mihaela Ginj; Stefan Jacobs; Amelie Lupp; Ralf Stumm; Stefan Schulz
Journal:  Mol Endocrinol       Date:  2010-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.